Two decades of research show that alcohol produces many of its addictive and organ-damaging effects by activating the endocannabinoid system, particularly CB1 receptors in the brain and liver.
Addiction researchers, hepatologists, neuroscientists, and clinicians treating alcohol use disorder.
CB1 receptors mediate both alcohol addiction and liver damage
What the researchers found
The review consolidates 20 years of evidence showing that alcohol increases endocannabinoid signaling, which mediates both its rewarding/addictive neural effects and its toxic effects in the liver (fatty liver disease). Both alcohol and endocannabinoids activate CB1 receptors to drive lipogenic gene expression. CB1 receptor blockade shows therapeutic potential for both alcohol addiction and alcohol-related liver disease.
Why it matters
Understanding that alcohol and cannabis share overlapping reward pathways through the endocannabinoid system explains why they are frequently co-used and why their combined effects can be more than additive.
The numbers in context
Over 20 years of accumulated evidence; both brain CB1 receptors (addiction) and liver CB1 receptors (fatty liver) implicated.
How the study worked
Narrative review synthesizing two decades of preclinical and clinical research on interactions between alcohol and the endocannabinoid system.
What this study cannot tell us
Narrative review format; much of the mechanistic evidence comes from animal models; CB1 blockade (rimonabant) was withdrawn due to psychiatric side effects, limiting translational potential.
How to read the evidence
Moderate: synthesizes two decades of consistent evidence but uses narrative review format.
When this study was published
Published 2020.
The bigger picture
The endocannabinoid system serves as a common pathway through which both alcohol and THC produce rewarding effects. This shared biology has implications for understanding co-use patterns and developing treatments that could address multiple substance use disorders simultaneously.
Questions still open
- Can peripheral-only CB1 blockers treat alcohol liver disease without the psychiatric side effects of brain-penetrant antagonists? How does this shared pathway affect people who use both alcohol and cannabis?
Common questions
How does alcohol interact with the endocannabinoid system?
Could blocking CB1 receptors treat alcoholism?
Read the original research
Interactions Between Alcohol and the Endocannabinoid System.
Alcoholism, clinical and experimental research, 44(4), 790-805
Citation
Kunos, George. (2020). Interactions Between Alcohol and the Endocannabinoid System.. Alcoholism, clinical and experimental research, 44(4), 790-805. https://doi.org/10.1111/acer.14306
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)